Jennifer Jarrett
CIK 1671311 · See Remarks · last filed 2026-06-22
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$23.01M
Companies
11
Total Filings
85
Lifetime Open-Market Net
-$11.77M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ZURA | Director | — | $5.54 | — | $0 | 3 | 2026-06-22 |
| SGMT | Director | — | $7.27 | — | $0 | 3 | 2026-06-15 |
| DMRA | See Remarks | 500,000 | $29.42 | $14.71M | $0 | 1 | 2026-04-01 |
| SNDX | Director | 114,000 | $19.63 | $2.24M | $0 | 9 | 2026-02-06 |
| RCUS | Chief Operating Officer | 224,024 | $27.05 | $6.06M | -$11.77M | 39 | 2026-01-26 |
| Zura Bio Ltd (ZURAW) Delisted | Director | — | $1.08 | — | $0 | 1 | 2023-05-22 |
| Radius Health, Inc. (RDUS) Delisted | Director | — | $30.00 | — | $0 | 2 | 2022-08-15 |
| ARENA PHARMACEUTICALS INC (ARNA) Delisted | Director | 3,067 | $99.99 | $306.7K | $0 | 6 | 2022-03-11 |
| SRZNW | 30,000 | $0.02 | $462 | $0 | 1 | 2021-08-13 | |
| BOLD | Director | — | $2.47 | — | $0 | 5 | 2020-01-15 |
| MEDIVATION, INC. (MDVN) Delisted | Chief Financial Officer | 29,971 | — | — | $0 | 1 | 2016-04-08 |
Recent Filings · Page 3 of 9
85 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-08-05 | SGMT | Grant (A) | — | $0 | EDGAR |
| 2024-06-18 | RCUS | Tax (F) | −12,670 | -$215.0K | EDGAR |
| 2024-03-29 | RCUS | Sell (S) | −11,551 | -$202.7K | EDGAR |
| 2024-03-27 | RCUS | Notice (144) | −56,551 | -$955.7K | EDGAR |
| 2024-03-20 | RCUS | Sell (S) | −13,449 | -$240.9K | EDGAR |
| 2024-03-15 | RCUS | Notice (144) | −16,000 | -$296.0K | EDGAR |
| 2024-02-28 | RCUS | Sell (S) | −58,625 | -$1.18M | EDGAR |
| 2024-02-09 | SNDX | Grant (A) | +17,000 | $0 | EDGAR |
| 2024-01-25 | RCUS | Grant (A) | +40,000 | $0 | EDGAR |
| 2023-12-26 | RCUS | Sell (S) | −21,521 | -$382.2K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.